Adaptimmune Therapeutics plc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ECOR1 CAPITAL, LLC | 02/14/2025 | 27.40 M | $14.76 M | 0.00% | 1.79% |
| LONG FOCUS CAPITAL MANAGEMENT, LLC | 02/14/2025 | 20.49 M | $11.04 M | 54.09% | 1.34% |
| NEA MANAGEMENT COMPANY, LLC | 02/14/2025 | 17.08 M | $9.20 M | 0.00% | 1.11% |
| TWO SEAS CAPITAL LP | 02/18/2025 | 14.84 M | $7.99 M | 100.00% | 0.97% |
| BAILLIE GIFFORD & CO | 01/31/2025 | 11.82 M | $6.37 M | -29.55% | 0.77% |
| MPM ASSET MANAGEMENT LLC | 02/14/2025 | 5.56 M | $2.99 M | 0.00% | 0.36% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 5.10 M | $2.75 M | 0.00% | 0.33% |
| PFM HEALTH SCIENCES, LP | 02/14/2025 | 4.87 M | $2.62 M | -51.28% | 0.32% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 2.53 M | $1.36 M | 52.51% | 0.16% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 2.48 M | $1.34 M | 2.39% | 0.16% |
| FMR LLC | 02/13/2025 | 1.76 M | $950,539 | 1.36% | 0.12% |
| JPMORGAN CHASE & CO | 02/12/2025 | 916,941 | $493,956 | -12.30% | 0.06% |
| REDMILE GROUP, LLC | 02/14/2025 | 715,607 | $385,497 | 0.00% | 0.05% |
| MARSHALL WACE, LLP | 02/13/2025 | 529,123 | $285,727 | 1.25% | 0.03% |
| ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 510,216 | $269,000 | 100.00% | 0.03% |
| RATHBONES GROUP PLC | 02/13/2025 | 432,818 | $233,159 | 0.00% | 0.03% |
| STATE STREET CORP | 02/14/2025 | 400,079 | $215,523 | 0.83% | 0.03% |
| JANE STREET GROUP, LLC | 02/14/2025 | 326,937 | $176,121 | 87.73% | 0.02% |
| KEY CLIENT FIDUCIARY ADVISORS, LLC | 01/17/2025 | 255,359 | $137,562 | 0.00% | 0.02% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 183,686 | $98,951 | -35.24% | 0.01% |
| UBS GROUP AG | 02/14/2025 | 141,744 | $76,400 | 7,700.99% | 0.01% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 139,801 | $75,310 | 0.00% | 0.01% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 122,696 | $66,000 | 21.47% | 0.01% |
| HRT FINANCIAL LP | 02/14/2025 | 83,199 | $44,000 | 100.00% | 0.01% |
| CAPTRUST FINANCIAL ADVISORS | 02/14/2025 | 81,629 | $43,974 | -1.70% | 0.01% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 76,347 | $41,128 | 33.47% | 0.01% |
| TWO SIGMA ADVISERS, LP | 02/14/2025 | 70,735 | $38,105 | 492.02% | 0.00% |
| WELLS FARGO & COMPANY/MN | 02/13/2025 | 63,967 | $34,459 | -4.27% | 0.00% |
| INVESCO LTD. | 02/13/2025 | 63,335 | $34,119 | 81.95% | 0.00% |
| BARCLAYS PLC | 02/13/2025 | 50,061 | $27,000 | 0.00% | 0.00% |
| PALISADES INVESTMENT PARTNERS, LLC | 02/18/2025 | 47,114 | $25,380 | 8.42% | 0.00% |
| VONTOBEL HOLDING LTD. | 01/30/2025 | 43,000 | $23,164 | 0.00% | 0.00% |
| GRAHAM CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 37,195 | $20,037 | 195.39% | 0.00% |
| OPPENHEIMER & CO INC | 02/05/2025 | 32,043 | $17,262 | -11.67% | 0.00% |
| RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 31,081 | $16,743 | 100.00% | 0.00% |
| CSS LLC/IL | 02/18/2025 | 30,702 | $16,539 | 0.00% | 0.00% |
| SIMON QUICK ADVISORS, LLC | 01/17/2025 | 30,000 | $16,161 | -1.48% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 29,559 | $15,923 | -95.87% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 29,150 | $15,703 | -84.62% | 0.00% |
| NEWMAN DIGNAN & SHEERAR, INC. | 01/30/2025 | 27,957 | $15,060 | 0.00% | 0.00% |
| WEALTH ENHANCEMENT ADVISORY SERVICES, LLC | 01/10/2025 | 26,816 | $25,486 | 147.93% | 0.00% |
| STIFEL FINANCIAL CORP | 02/13/2025 | 26,469 | $14,258 | -4.16% | 0.00% |
| HSBC HOLDINGS PLC | 02/14/2025 | 26,064 | $14,335 | 0.00% | 0.00% |
| HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC | 01/23/2025 | 22,000 | $12,000 | -4.35% | 0.00% |
| PROSPERITY WEALTH MANAGEMENT, INC. | 02/07/2025 | 21,870 | $11,781 | -11.17% | 0.00% |
| GROUP ONE TRADING, L.P. | 02/14/2025 | 20,515 | $11,051 | -57.59% | 0.00% |
| RHUMBLINE ADVISERS | 01/30/2025 | 19,748 | $10,638 | 3.07% | 0.00% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2025 | 19,530 | $10,527 | 318.65% | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 19,500 | $10,530 | -40.37% | 0.00% |
| KINGSWOOD WEALTH ADVISORS, LLC | 01/22/2025 | 18,690 | $10,068 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Adaptimmune Therapeutics plc institutional Ownership - FAQ's
During the previous two years, 105 institutional investors and hedge funds held shares of Adaptimmune Therapeutics plc. The most heavily invested institutionals were:
EcoR1 Capital, LLC: 27.4 M
Long Focus Capital Management, LLC: 20.49 M
NEA Management Company, LLC: 17.08 M
Two Seas Capital LP: 14.84 M
BAILLIE GIFFORD & CO: 11.82 M
MPM ASSET MANAGEMENT LLC: 5.56 M
8.11% of Adaptimmune Therapeutics plc stock is owned by institutional investors.
Institutional investors have bought a total of 126.74 M shares in the last 24 months. This purchase volume represents approximately $82.38 M in transactions.